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Clinical PerspectiveWhat Is New?This is the first study to demonstrate a relationship between the incidence of acidosis and contrast‐induced nephropathy in patients with a first‐time ST‐segment elevation myocardial infarction.What Are the Clinical Implications?Since acidosis defined by arterial blood pH is a noninvasive and simple method, it is clinically useful and helpful as a marker of risk stratification for contrast‐induced nephropathy.

Introduction {#jah32363-sec-0008}
============

Contrast‐induced nephropathy (CIN) is associated with poor outcomes in patients with acute myocardial infarction (AMI).[1](#jah32363-bib-0001){ref-type="ref"}, [2](#jah32363-bib-0002){ref-type="ref"}, [3](#jah32363-bib-0003){ref-type="ref"}, [4](#jah32363-bib-0004){ref-type="ref"}, [5](#jah32363-bib-0005){ref-type="ref"}, [6](#jah32363-bib-0006){ref-type="ref"} CIN is caused by renal vasoconstriction, renal hypoxia, and direct toxicity on tubular epithelial cells caused by contrast medium exposure. Many factors have been reported as predictors of CIN (advanced age, female sex, chronic kidney disease, heart failure, reduced ejection fraction, anemia, high‐sensitivity C‐reactive protein \[hs‐CRP\], glucose level on admission, diabetes mellitus, high doses of contrast medium, etc).[7](#jah32363-bib-0007){ref-type="ref"}, [8](#jah32363-bib-0008){ref-type="ref"}, [9](#jah32363-bib-0009){ref-type="ref"}, [10](#jah32363-bib-0010){ref-type="ref"}, [11](#jah32363-bib-0011){ref-type="ref"}, [12](#jah32363-bib-0012){ref-type="ref"}, [13](#jah32363-bib-0013){ref-type="ref"}, [14](#jah32363-bib-0014){ref-type="ref"} In addition, some risk scoring systems have been used to predict CIN in a clinical setting.[7](#jah32363-bib-0007){ref-type="ref"}, [15](#jah32363-bib-0015){ref-type="ref"} However, the predictors of CIN are yet to be fully elucidated.

AMI leading to congestive heart failure or cardiogenic shock may cause renal dysfunction attributable to acute kidney injury (AKI). In patients with AMI, acute kidney injury is caused not only by contrast medium exposure but also by changes in hemodynamic status. Although there are some compounding factors in the definition of CIN in patients with AMI, CIN is generally defined as an increase of 0.5 mg/dL in serum creatinine or a 25% increase from baseline between 48 and 72 hours after contrast medium exposure. In the clinical setting, blood pressure or Killip classification are commonly used to assess the hemodynamic status of patients with AMI. However, it can often be difficult to evaluate hemodynamic status precisely based on such parameters alone. Right heart catheterization is considered the best method for evaluating hemodynamic status precisely; however, it is an invasive method. On the other hand, arterial blood gas (ABG) analysis, which is a noninvasive and simple method, can be used to evaluate acid--base status, directly reflecting hemodynamic status. We hypothesized that the incidence of acidosis evaluated using ABG could predict CIN in patients with AMI.

Methods {#jah32363-sec-0009}
=======

Patients {#jah32363-sec-0010}
--------

This was a retrospective study conducted between October 2010 and March 2016. A total of 331 consecutive patients, who had undergone emergency coronary angiography and had a significant stenotic culprit lesion, were screened. All patients had a first‐time ST‐segment elevation myocardial infarction (STEMI) and were reperfused within 12 hours of symptom onset in Saiseikai Yokohamashi Nanbu Hospital, Japan. STEMI was defined as chest pain lasting for at least 30 minutes accompanied by new ST‐segment elevation and a rise in cardiac‐specific troponin levels as a value exceeding the 99th percentile of a normal reference population.[16](#jah32363-bib-0016){ref-type="ref"} ST‐segment elevation was defined as new ST‐segment elevation at the J point in at least 2 contiguous leads of 0.2 mV in men or 0.15 mV in women in leads V2 to V3, or of 0.1 mV in other leads. New left bundle‐branch block was considered equivalent to STEMI. We excluded patients with any of the following characteristics: mechanical ventilation, hemodialysis, or a history of previous coronary‐artery bypass grafting. A total of 273 patients met the eligibility criteria and were enrolled in the study. Forty‐six patients with mechanical ventilation, 10 patients undergoing hemodialysis, and 2 patients with previous coronary‐artery bypass grafting were excluded (Figure [1](#jah32363-fig-0001){ref-type="fig"}). Of the 273 patients, 243 underwent stent implantation, 8 underwent balloon angioplasty only, 17 underwent thrombus aspiration only, 2 with spontaneous reperfusion underwent coronary‐artery bypass grafting, and 3 with spontaneous reperfusion received medical therapy only. We divided the patients into 2 groups according to the incidence of CIN (ie, those who developed CIN and those who did not). Following admission, 5000 U of unfractionated heparin was administered to patients. Subsequently, they received aspirin (200 mg loading dose, followed by 100 mg/day), and either clopidogrel (300 mg loading dose, followed by 75 mg/day) or prasugrel (20 mg loading dose, followed by 3.75 mg/day as prasugrel is in general use in Japan). Glycoprotein (GP) IIb/IIIa inhibitors were not used as they have not been approved for use in Japan. The study protocol was approved by the Saiseikai Yokohamashi Nanbu Hospital Institutional Review Board and the subjects gave informed consent.

![Study flow chart. Of the 331 screened patients, 273 were enrolled in the present study. CABG indicates coronary artery bypass grafting; STEMI,ST‐segment elevation myocardial infarction.](JAH3-6-e006380-g001){#jah32363-fig-0001}

Blood Sampling {#jah32363-sec-0011}
--------------

Biochemistry data including creatine phosphokinase and creatine kinase MB were evaluated on admission, at 3‐hour intervals during the first 24 hours, and then daily during the first 3 days following admission. Glucose levels, hemoglobin A1c, and hs‐CRP were evaluated on admission. Serum creatinine and estimated glomerular filtration rate (eGFR) were evaluated daily during the first 3 days according to the following formula.[17](#jah32363-bib-0017){ref-type="ref"} $$\text{eGFR}\mspace{720mu}{(\text{mL/min\ per}\mspace{720mu} 1.73\, m^{2})} = 194 \times \text{Serum}\mspace{6mu}\text{creatinine}^{- 1.094} \times \text{Age}^{- 0.287} \times 0.739\mspace{720mu}{(\text{if\ female})}$$

CIN was defined as an increase of 0.5 mg/dL in serum creatinine or a 25% increase from baseline between 48 and 72 hours after contrast medium exposure.

ABG Protocol {#jah32363-sec-0012}
------------

Shortly after reperfusion, blood samples were obtained from the sheath. All patients underwent ABG analysis. Arterial blood pH, partial pressure of arterial oxygen, partial pressure of arterial carbon dioxide, hydrogen carbonate ion (HCO^3−^), and base excess were evaluated. Acidosis was defined as an arterial blood pH \<7.35. Metabolic acidosis was defined as an arterial blood pH \<7.35 with HCO^3−^ \<22 mmol/L. Respiratory acidosis was defined as an arterial blood pH \<7.35 with partial pressure of arterial carbon dioxide level \>45 mm Hg.

Two‐Dimensional Echocardiography Protocol {#jah32363-sec-0013}
-----------------------------------------

All patients underwent 2‐dimensional echocardiography on admission, immediately after reperfusion. All images were obtained with a commercial ultrasound system in the parasternal (long‐ and short‐axis) and 3‐apical (2‐, 3‐, and 4‐chamber) views with a 3‐MHz phased array probe. Grayscale images were obtained at a frame rate of ≥50 per second. The images were independently interpreted by experienced sonographers blinded to the angiographic and clinical data. Complete 2‐dimensional, color, pulsed, and continuous‐wave Doppler echocardiography was obtained according to standard techniques. Left ventricular ejection fraction (LVEF) and transmitral deceleration time were obtained.

Risk Scoring of CIN {#jah32363-sec-0014}
-------------------

Many factors have been reported as predictors of CIN. Recently, Mehran et al demonstrated a simple risk score (Mehran risk score) for CIN after percutaneous coronary intervention.[7](#jah32363-bib-0007){ref-type="ref"} It was calculated by evaluating the presence of hypotension, congestive heart failure, anemia, and diabetes mellitus, the use of intra‐aortic balloon pump, age \>75 years, the amount of contrast medium, and the basal renal function. We calculated Mehran risk scores and compared them with acidosis to predict CIN in the present study.

We investigated whether the incidence of acidosis soon after reperfusion was a predictor of CIN when adjusted for well‐known predictors or risk scoring system. Additionally, we investigated the association between the incidence of CIN and in‐hospital mortality rate.

Statistical Analysis {#jah32363-sec-0015}
--------------------

Continuous variables were expressed as means±SD for normally distributed variables, and as medians (25th to 75th percentiles) for variables with skewed distributions. Differences between the groups were tested using Student *t* test for normally distributed variables, the Mann--Whitney test for variables with skewed distributions, and the χ^2^ test or Fisher exact test as appropriate for categorical variables. Univariate variables to predict CIN were analyzed, and variables with *P*\<0.2 on univariate analysis were entered into a multivariable logistic analysis with forward stepwise algorithm. Peak creatine phosphokinase, serum creatinine, metabolic acidosis, and respiratory acidosis were excluded because of the effect of confounding factors. We then established multivariable logistic regression analysis using forced inclusion models for the prediction of CIN (model‐1: age, male sex, body mass index, and the incidence of acidosis; model‐2: amount of contrast medium, eGFR on admission, and the incidence of acidosis; model‐3: glucose level on admission, hs‐CRP on admission, the incidence of acidosis, and LVEF; model‐4: the incidence of acidosis and Mehran risk score). All statistical tests were 2‐tailed, and *P*\<0.05 was considered to indicate statistical significance. SPSS version 18.0 (SPSS Japan Inc, Tokyo, Japan) was used for all statistical analyses.

Results {#jah32363-sec-0016}
=======

Baseline and Clinical Characteristics {#jah32363-sec-0017}
-------------------------------------

Baseline and clinical characteristics are shown in Table [1](#jah32363-tbl-0001){ref-type="table-wrap"}. CIN was observed in 35 patients (12.8%). Patients with CIN had higher age, longer reperfusion times, higher prevalence of hypertension, higher glucose level on admission, higher peak creatine phosphokinase and creatine kinase MB, and higher hs‐CRP on admission than those without CIN (all *P*\<0.05). In addition, patients with CIN had higher incidence of acidosis (especially respiratory acidosis) than those without CIN (*P*=0.014). Two‐dimensional echocardiography findings revealed that patients with CIN had slightly lower LVEF than those without CIN (55% versus 57%, *P*=0.049). Moreover, patients with CIN had higher Mehran risk score of CIN than those without CIN (6 versus 4, *P*=0.022). Conversely, although in previous studies, the prevalence of Killip class \>1 tended to be associated with CIN, it did not reach statistical significance in the present study (*P*=0.050). Furthermore, in the present study, there were no significant differences between the 2 groups regarding the prevalence of diabetes mellitus, amount of contrast medium, serum creatinine, and eGFR on admission, which were the well‐known predictors of CIN previously (*P*=0.728, 0.970, 0.305, and 0.451, respectively).

###### 

Baseline and Clinical Characteristics

  Variables                                 With CIN (n=35)     Without CIN (n=238)   *P* Value
  ----------------------------------------- ------------------- --------------------- -----------
  Age, y                                    75 (64--80)         68 (60--76)           0.041
  Male, n (%)                               27 (77)             188 (79)              0.803
  Body mass index, kg/m^2^                  23 (22--25)         24 (22--26)           0.708
  Killip class \>1, n (%)                   8 (23)              25 (11)               0.050
  Reperfusion time, h                       3.9 (2.4--6.0)      2.8 (2.0--4.0)        0.004
  Culprit artery                                                                      0.422
  Left anterior descending artery, n (%)    20 (57)             113 (47)              
  Right coronary artery, n (%)              9 (26)              88 (37)               
  Left circumflex artery, n (%)             6 (17)              37 (16)               
  Number of diseased vessels, n (%)                                                   0.411
  1                                         15 (43)             123 (51)              
  2                                         15 (43)             75 (32)               
  3                                         5 (14)              40 (17)               
  Amount of contrast medium, mL             133 (100--200)      135 (104--160)        0.970
  Current smoker, n (%)                     15 (43)             88 (37)               0.503
  Hypertension, n (%)                       27 (77)             128 (54)              0.009
  Dyslipidemia, n (%)                       25 (71)             195 (82)              0.142
  Diabetes mellitus, n (%)                  11 (31)             68 (29)               0.728
  Glucose level on admission, mg/dL         192 (153--213)      152 (125--201)        0.004
  Hemoglobin A1c, %                         5.8 (5.7--6.6)      6.0 (5.7--6.5)        0.614
  Peak CPK, IU/L                            2323 (1298--6142)   1535 (695--3112)      0.012
  Peak CK‐MB, IU/L                          233 (184--599)      172 (74--334)         0.008
  hs‐CRP on admission, mg/dL                0.20 (0.07--0.94)   0.10 (0.05--0.25)     0.008
  Serum creatinine, mg/dL                   0.82 (0.64--1.27)   0.90 (0.80--1.05)     0.305
  eGFR on admission, mL/min per 1.73 m^2^   68 (43--84)         63 (52--71)           0.451
  Acidosis, n (%)                           12 (34)             40 (17)               0.014
  Metabolic acidosis, n (%)                 7 (20)              20 (8)                0.061
  Respiratory acidosis, n (%)               5 (14)              8 (3)                 0.016
  LVEF, %                                   55 (47--60)         57 (51--62)           0.049
  DcT, ms                                   191 (169--217)      209 (172--259)        0.144
  Mehran risk score                         6 (4--11)           4 (1--8)              0.022

Data are displayed as mean±SD or number (percentage) or median (range). CIN indicates contrast‐induced nephropathy; CK‐MB, creatine kinase MB; CPK, creatine phosphokinase; DcT, deceleration time; eGFR, estimated glomerular filtration rate; hs‐CRP, high‐sensitivity C‐reactive protein; LVEF, left ventricular ejection fraction.

In‐Hospital Mortality {#jah32363-sec-0018}
---------------------

In‐hospital mortality rate was higher in patients with CIN (11.4%, 4 of 35 patients) than in patients without CIN (2.1%, 5 of 238 patients) (*P*=0.018, Figure [2](#jah32363-fig-0002){ref-type="fig"}).

![The association between the incidence of CIN and in‐hospital mortality rate. In‐hospital mortality rate was higher in patients with CIN (11.4%, 4 of 35 patients) than that in patients without CIN (2.1%, 5 of 238 patients) (*P*=0.018). CIN indicates contrast‐induced nephropathy.](JAH3-6-e006380-g002){#jah32363-fig-0002}

Univariate Logistic Regression Analysis to Predict CIN {#jah32363-sec-0019}
------------------------------------------------------

Univariate logistic analysis revealed that there was a significant association between CIN and the following: Killip class \>1, reperfusion time, the prevalence of hypertension, glucose level on admission, peak creatine kinase MB, hs‐CRP on admission, the incidence of acidosis, LVEF, and Mehran risk score (all *P*\<0.05, Table [2](#jah32363-tbl-0002){ref-type="table-wrap"}). In contrast, age, male sex, body mass index, and dyslipidemia were not associated with CIN in the present study (*P*=0.051, 0.803, 0.648, and 0.147, respectively, Table [2](#jah32363-tbl-0002){ref-type="table-wrap"}). In addition, the amount of contrast medium and eGFR on admission, which were the well‐known predictors of CIN previously, were not associated with CIN in the present study (*P*=0.740 and 0.592, Table [2](#jah32363-tbl-0002){ref-type="table-wrap"}).

###### 

Univariate and Multivariable Logistic Regression Analyses to Predict CIN

  Variables                                       Univariate   Multivariable (Stepwise)   Multivariable (Forced Inclusion Model 1)                                                                             
  ----------------------------------------------- ------------ -------------------------- ------------------------------------------ -------------- ---------------- ---------------- ------- ---------------- -------
  Age, per 1 y                                    1.030        1.000 to 1.062             0.051                                                                      0.227            1.034   1.000 to 1.069   0.053
  Male                                            0.898        0.384 to 2.097             0.803                                      Not selected   1.299            0.522 to 3.229   0.574                    
  Body mass index, per 1 kg/m^2^                  0.975        0.875 to 1.087             0.648                                      Not selected   1.016            0.902 to 1.145   0.618                    
  Killip class \>1                                2.524        1.035 to 6.154             0.042                                                                      0.664            ···                      
  Reperfusion time, per 1 h                       1.217        1.077 to 1.375             0.002                                      1.202          1.044 to 1.385   0.011            ···                      
  Amount of contrast medium, per 1 mL             1.001        0.994 to 1.008             0.740                                      Not selected   ···                                                        
  Hypertension                                    2.900        1.266 to 6.645             0.012                                      3.168          1.292 to 7.772   0.012            ···                      
  Dyslipidemia                                    0.551        0.247 to 1.232             0.147                                                                      0.337            ···                      
  Glucose level on admission, per 1 mg/dL         1.006        1.001 to 1.011             0.017                                                                      0.093            ···                      
  Peak CK‐MB, per 1 IU/L                          1.002        1.001 to 1.004             0.001                                      1.002          1.000 to 1.004   0.017            ···                      
  hs‐CRP on admission, per 1 mg/dL                1.246        1.025 to 1.514             0.027                                      1.245          1.034 to 1.498   0.020            ···                      
  eGFR on admission, per 1 mL/min per 1.73 m^2^   1.005        0.986 to 1.026             0.592                                      Not selected   ···                                                        
  Acidosis                                        2.583        1.188 to 5.613             0.017                                      2.713          1.113 to 6.616   0.028            2.548   1.160 to 5.593   0.020
  LVEF, %                                         0.959        0.921 to 0.997             0.035                                                                      0.712            ···                      
  Mehran risk score                               1.081        1.016 to 1.150             0.014                                                                      0.458            ···                      

  Variables                                       Multivariable (Forced Inclusion Model 2)   Multivariable (Forced Inclusion Model 3)   Multivariable (Forced Inclusion Model 4)                                                                      
  ----------------------------------------------- ------------------------------------------ ------------------------------------------ ------------------------------------------ ---------------- ---------------- ------- ------- ---------------- -------
  Age, per 1 y                                    ···                                        ···                                        ···                                                                                                           
  Male                                            ···                                        ···                                        ···                                                                                                           
  Body mass index, per 1 kg/m^2^                  ···                                        ···                                        ···                                                                                                           
  Killip class \>1                                ···                                        ···                                        ···                                                                                                           
  Reperfusion time, per 1 h                       ···                                        ···                                        ···                                                                                                           
  Amount of contrast medium, per 1 mL             1.001                                      0.994 to 1.008                             0.871                                      ···              ···                                               
  Hypertension                                    ···                                        ···                                        ···                                                                                                           
  Dyslipidemia                                    ···                                        ···                                        ···                                                                                                           
  Glucose level on admission, per 1 mg/dL         ···                                        1.005                                      1.000 to 1.010                             0.064            ···                                               
  Peak CK‐MB, per 1 IU/L                          ···                                        ···                                        ···                                                                                                           
  hs‐CRP on admission, per 1 mg/dL                ···                                        1.204                                      1.007 to 1.440                             0.042            ···                                               
  eGFR on admission, per 1 mL/min per 1.73 m^2^   1.009                                      0.989 to 1.030                             0.394                                      ···              ···                                               
  Acidosis                                        2.721                                      1.235 to 5.995                             0.013                                      2.452            1.095 to 5.495   0.029   2.229   1.004 to 4.949   0.049
  LVEF, %                                         ···                                        0.971                                      0.932 to 1.012                             0.167            ···                                               
  Mehran risk score                               ···                                        ···                                        1.069                                      1.003 to 1.139   0.041                                             

The table lists all the analyzed variables. Forced inclusion model 1: age, male, body mass index, and the incidence of acidosis. Forced inclusion model 2: amount of contrast medium, eGFR on admission, and the incidence of acidosis. Forced inclusion model 3: glucose level on admission, hs‐CRP on admission, the incidence of acidosis, and LVEF. Forced inclusion model 4: the incidence of acidosis and Mehran risk score. CI indicates confidence interval; CIN, contrast‐induced nephropathy; CK‐MB, creatine kinase MB; eGFR, estimated glomerular filtration rate; hs‐CRP, high‐sensitivity C‐reactive protein; LVEF, left ventricular ejection fraction; OR, odds ratio.

Multivariable Logistic Regression Analysis to Predict CIN {#jah32363-sec-0020}
---------------------------------------------------------

A multivariable logistic analysis with forward stepwise algorithm and *P*\<0.2 on univariate analysis revealed that reperfusion time, the prevalence of hypertension, peak creatine kinase MB, hs‐CRP on admission, and the incidence of acidosis were significantly associated with CIN (all *P*\<0.05, Table [2](#jah32363-tbl-0002){ref-type="table-wrap"}). Multivariable logistic regression analysis by forced inclusion models for prediction of CIN revealed that the incidence of acidosis was associated with CIN when adjusted for age, male sex, body mass index, amount of contrast medium, eGFR on admission, glucose levels on admission, hs‐CRP on admission, and LVEF (model 1 to model 3 in Table [2](#jah32363-tbl-0002){ref-type="table-wrap"}). In addition, the incidence of acidosis was associated with CIN when adjusted for Mehran risk score (odds ratio: 2.229, 95% CI \[confidence interval\]: 1.004--4.94, *P*=0.049, model 4 in Table [2](#jah32363-tbl-0002){ref-type="table-wrap"}). According to these results, the incidence of acidosis was associated with CIN when adjusted for well‐known predictors or risk scoring systems in the present study.

Discussion {#jah32363-sec-0021}
==========

The principal finding of the present study was that the incidence of acidosis soon after reperfusion was associated with CIN when adjusted for other risk factors or risk scoring system in patients with a first‐time STEMI and reperfused within 12 hours of symptom onset. To the best of our knowledge, this is the first study to demonstrate a relationship between the incidence of acidosis and CIN.

Acidosis {#jah32363-sec-0022}
--------

Decreased cardiac output because of AMI may lead to a disturbance in the metabolism of peripheral tissue, resulting in metabolic acidosis. In addition, respiratory failure caused by congestive heart failure resulting from AMI may lead to respiratory acidosis. Acidosis inhibits the myofibrillar responsiveness to Ca^2+^ by decreasing the sensitivity of contractile proteins to Ca^2+^ and by decreasing maximum force.[18](#jah32363-bib-0018){ref-type="ref"} Acidosis decreases the myocardial contractility and energy production. In addition, the mechanical function is depressed in ischemia not only in anoxic regions of the heart but also in adjacent aerobic regions because of the pH change.[19](#jah32363-bib-0019){ref-type="ref"} Thus, patients with acidosis are caught in a vicious circle. Some previous reports have demonstrated that the evaluation of acid--base status was helpful in risk stratification in patients with AMI.[20](#jah32363-bib-0020){ref-type="ref"}, [21](#jah32363-bib-0021){ref-type="ref"} In addition, Nagai et al demonstrated that acidosis and subsequent inflammation following reperfusion after STEMI played an important role in the development of sustained ventricular tachycardia and ventricular fibrillation.[22](#jah32363-bib-0022){ref-type="ref"} Moreover, Park et al demonstrated that acidosis was observed in every fifth patient and was a significant predictor of mortality in patients with acute heart failure.[23](#jah32363-bib-0023){ref-type="ref"} Hence, it is important to evaluate the acid--base status for risk stratification in patients with AMI.

Recently, the association between acidosis and reperfusion injury has been focused upon. Reperfusion injury (ie, myocardial injury resulting in additional myocardial necrosis or arrhythmias) is caused by the restoration of coronary blood flow after an ischemic episode. Several studies have been undertaken in an attempt to overcome this particular issue. Preckel et al demonstrated that reperfusion injury after coronary artery occlusion could be reduced by prolonged local extracellular acidosis in vivo.[24](#jah32363-bib-0024){ref-type="ref"} In addition, Kitakaze et al demonstrated that temporary acidosis during reperfusion limited the infarct size in dogs.[25](#jah32363-bib-0025){ref-type="ref"} Moreover, Zhao et al demonstrated that repetitive cycles of briefly interrupted reperfusion at the onset of coronary reflow significantly reduced the infarct size, and they referred to this procedure as postconditioning.[26](#jah32363-bib-0026){ref-type="ref"} Prolongation of intracellular acidosis during initial reperfusion protects against ischemia, reperfusion--induced hypercontracture, and cell death.[27](#jah32363-bib-0027){ref-type="ref"} In postconditioning, prolonged temporary acidosis in the first minutes of reperfusion occurs via the activation of Akt and extracellular signal--regulated kinase, which prevents mitochondrial permeability transition pore formation after pH normalization.[28](#jah32363-bib-0028){ref-type="ref"}, [29](#jah32363-bib-0029){ref-type="ref"} Furthermore, acidosis and subsequent activation of Na^+^/H^+^ exchange has been shown to modulate the production of endogenous NO in canine ischemic myocardium.[30](#jah32363-bib-0030){ref-type="ref"} In addition, acidosis leading to increased H^+^ activity may contribute to local regulation of coronary blood flow by altering the vasoactivity of adenosine.[31](#jah32363-bib-0031){ref-type="ref"} Moreover, the opening of ATP‐sensitive potassium channels in vascular smooth muscle mediates coronary arteriolar dilation during acidosis.[32](#jah32363-bib-0032){ref-type="ref"} Although these compensatory responses after acidosis contribute to the effects of postconditioning, the significance of acidosis as a marker of risk stratification as shown in the present study differs from that of artificial acidosis as postconditioning.

Contrast‐induced Nephropathy {#jah32363-sec-0023}
----------------------------

Although there are some compounding factors in the definition of CIN in patients with AMI as mentioned above, CIN is a powerful predictor of major adverse clinical events in these patients.[1](#jah32363-bib-0001){ref-type="ref"}, [2](#jah32363-bib-0002){ref-type="ref"}, [3](#jah32363-bib-0003){ref-type="ref"}, [4](#jah32363-bib-0004){ref-type="ref"}, [5](#jah32363-bib-0005){ref-type="ref"}, [6](#jah32363-bib-0006){ref-type="ref"} In the present study, we demonstrated that the in‐hospital mortality rate was higher in patients with CIN than in patients without CIN, and the incidence of acidosis soon after reperfusion was associated with CIN when adjusted for well‐known predictors or risk scoring system. Since ABG analysis is a noninvasive and simple method, it is clinically useful and helpful.

Although acidosis was not only considered a marker of the risk stratification for CIN but also a mediator of CIN because of decreasing myocardial contractility, it is still not clear whether the intervention to prevent acidosis can improve the prognosis. de Brito‐Ashurst et al demonstrated that oral sodium bicarbonate slowed the progression of chronic kidney disease.[33](#jah32363-bib-0033){ref-type="ref"} Additionally, some previous reports revealed that hydration with sodium bicarbonate improved acidosis as the rapid increase of intravascular volume was more effective than hydration with sodium chloride for prophylaxis of CIN.[34](#jah32363-bib-0034){ref-type="ref"}, [35](#jah32363-bib-0035){ref-type="ref"} In contrast, previous reports have shown that hydration with sodium bicarbonate had no clinical superiority in reducing the risk of CIN than that with sodium chloride.[36](#jah32363-bib-0036){ref-type="ref"}, [37](#jah32363-bib-0037){ref-type="ref"}, [38](#jah32363-bib-0038){ref-type="ref"}, [39](#jah32363-bib-0039){ref-type="ref"} Since there is no evidence that hydration with sodium bicarbonate decreases the risk of hemodialysis or death, the effect of intervention for acidosis prevention may have a limited impact on CIN. Hence, now we conclude that acidosis is useful as a marker of risk stratification for CIN. However, there is a possibility that the use of sodium bicarbonate may decrease the risk of CIN via a rapid increase of intravascular volume in patients with STEMI. If the intervention to acidosis itself has a preferable effect in those patients, we can conclude that the intervention to acidosis itself may be a good option in patients with AMI as well as postconditioning as artificial acidosis. On the other hand, if the intervention to acidosis itself does not have a preferable effect in those patients, we can conclude that acidosis is just a marker of risk stratification. Further studies are needed to draw this conclusion.

Limitations {#jah32363-sec-0024}
-----------

Our study had several limitations. First, it was a retrospective observational study, and the study group comprised a relatively small number of patients enrolled at a single center. Second, there was some bias regarding the amount of contrast medium used during reperfusion therapy, as we were aware of the baseline eGFR on admission. Hence, the amount of contrast medium and eGFR on admission might not be predictors of CIN in the present study. In addition, low power might be a possible explanation that some well‐known risk factors including the amount of contrast medium and eGFR on admission failed to reach statistical significance in the present study. Since the amount of contrast medium and eGFR on admission are established predictors of CIN, there is an ethical issue if we conduct a blind study regarding the baseline eGFR. Therefore, it is difficult to completely avoid this problem. However, we thought that our results had significance in clinical practice in which we were aware of the baseline eGFR. Third, since we excluded high‐risk patients such as those who needed mechanical ventilation, hemodialysis, or those who had a history of coronary‐artery bypass grafting, our findings may not apply to these subgroups of patients. However, we believe that our findings are of clinical significance in most patients.

Conclusion {#jah32363-sec-0025}
==========

The incidence of acidosis soon after reperfusion was associated with CIN when adjusted for other risk factors or risk scoring system in patients with a first‐time STEMI who were reperfused within 12 hours of symptom onset.
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